Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact of Apixaban on clinical outcome of the patients with Large Vessel Occlusion or stenosis

Trial Profile

Impact of Apixaban on clinical outcome of the patients with Large Vessel Occlusion or stenosis

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Apixaban (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms ALVO trial
  • Most Recent Events

    • 21 Feb 2020 Results estimating the cumulative incidences of bleeding and ischemic events as well as all-cause mortality in patients on apixaban for nonvalvular atrial fibrillation and and acute large vessel occlusion, presented at the International Stroke Conference 2020
    • 03 Aug 2019 Status changed from recruiting to completed.
    • 22 Jun 2016 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top